BD (NYSE:BDX) announced yesterday that it launched the HemoSphere Stream module for blood pressure monitoring.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has been recognized by the Healthcare Industry Resilience Collaborative (HIRC) as the only supplier to ...

Ever since COVID hit, supply chain executives have embraced supply chain risk management. Within this discipline, one of the toughest challenges is how to get visibility to problems arising across the ...

BD (NYSE:BDX) announced today that EVP and President of Interventional, Rick Byrd, informed the company that he intends to ...

BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health (TM) by driving innovation across medical essentials, connected care, biopharma ...

Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...

After racking up a string of acquisitions throughout 2022—including one of the medtech industry’s largest of the year in its $1.5 billion buyout of Parata Systems—BD has yet to make any major ...

BD's HemoSphere Stream Module delivers real-time, noninvasive blood pressure monitoring, enhancing patient safety and ...

BD has settled on a new name for its new company, the independent spinout that will house its billion-dollar diabetes care business. Embecta is set to launch as its own, publicly traded brand in the ...

Becton, Dickinson and Co. plans to invest more than $110 million to expand a prefilled flush syringe manufacturing facility in Nebraska. According to BD, the plan aims to better meet growing demand ...